

There are parts of the stock market where I am comfortable doing the research myself.Give me a community bank’s balance sheet, loan portfolio, and deposit...
You can purchase shares of OnKure Therapeutics (NASDAQ:OKUR) through any online brokerage.
Other companies in OnKure Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
OnKure Therapeutics has a consensus price target of $26.00.
The stock price for OnKure Therapeutics (NASDAQ: OKUR) is $2.62 last updated October 30, 2026 at 4:00 PM EDT.
There are no upcoming dividends for OnKure Therapeutics.
OnKure Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for OnKure Therapeutics.
OnKure Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a...